SBIR/STTR Research Award

CROSS-AXIS COIL PLANET CENTRIFUGE CHROMATOGRAPH DESIGN AND SYNTHESIS OF BRAIN-SPECIFIC ANTIHERPETIC AGENTS

Award identifier 1d5e58adab08c091467fa54194125bf8e1aa2d66130d2ac2e938eda84b843a15Awarding agency Department of Health and Human Services

Award amount

$416,005

Program and phase

SBIR · Phase II

Award year

1989

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
Pharmos Corporation
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

A NEW COUNTERCURRENT CHROMATOGRAPHY INSTRUMENT, THE CROSS-AXIS FLOW-THROUGH COIL PLANET CENTRIFUGE IS PROPOSED FOR THE PREPARATIVE CHROMATOGRAPHY OF PEPTIDES. THIS IS AN APPARATUS THAT SEPARATES SUBSTANCES ACCORDING TO THEIR PARTITIONING IN A LIQUID-LIQUID EQUILIBRATION SYSTEM WITHOUTTHE USE OF A SOLID-PHASE SUPPORT. THE INSTRUMENT WILL BE TESTED IN THE PURIFICATION OF LARGE QUANTITIES OF SYNTHETIC PEPTIDES, USING DIFFERENT CONDITIONS AND SOLVENT SYSTEMS TO ACHIEVE HIGH RESOLUTION AND RECOVERY. THE SUCCESSFUL DEVELOPMENT OF THIS INSTRUMENT WOULD MAKE AVAILABLE A LOWER COST TECHNOLOGY FOR CHROMATOGRAPHIC PURIFICATION. THE IMPEDIMENTS ENCOUNTERED IN THE TREATMENT OF HUMAN BRAIN ENCEPHALITIS HAVE SO FAR BEEN ATTRIBUTED TO THE INABILITY OFANTIVIRAL AGENTS TO REACH THE VIRAL SITE IN THE CNS. TO CIRCUMVENT THESE PROBLEMS UTILIZATION OF THE BRAIN-SPECIFIC CHEMICAL DELIVERY SYSTEM (ANALOGOUS TO THE NAD NADHREDOX SYSTEM) DEVELOPED BY BODOR AND ASSOCIATES IS PROPOSED. THIS SYSTEM IS BASED ON THE INTERCONVERSION OF LIPOPHILIC DIHYDROPYRIDINES WHICH READILY CROSS THE BBB BETWEEN HYDROPHILIC PYRIDINIUM SALTS WHICH ARE LOCKED IN THEBRAIN. THE ADVANTAGES OF THIS SYSTEM ARE 1) LOWER PERIPHERAL CONCENTRATIONS OF THE ACTIVE AGENT AND CONSEQUENTLY REDUCED SYSTEMIC TOXICITY 2) GREATER EFFICACY SINCE A LOWER DOSE CAN BE GIVEN TO ATTAIN CLINICALLY EFFECTIVE CEREBRAL CONCENTRATIONS. THE MAJOR AIM OF THIS PROPOSAL IS TO APPLY THE CHEMICAL DELIVERY SYSTEM TO SELECTED ANTIHERPETIC AGENTS. THE AREAS OF RESEARCH IN PHASE I WOULD INCLUDE SYNTHESIS OF DRUG-CARRIER SYSTEMS, DEVELOPMENT OF SUITABLE ANALYTICAL SYSTEMS, DETERMINATION OFSTABILITY IN VITRO USING VARIOUS MATRICES TO ESTABLISH THE RATE AT WHICH THE FREE DRUG IS RELEASED FROM THE CARRIER. EVALUATION OF THE LIPOPHILICITY AND NEUROTOXICITY OF DRUG-CARRIER SYSTEMS. IN PHASE II BASED ON THE RESULTS FROMPHASE I AT LEAST TWO COMPOUNDS WILL BE SELECTED FOR IN-DEPTH IN VIVO DISTRIBUTION AND ACTIVITY STUDIES.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.